Nov 10, 2025 07:42AM
Nov 10, 2025 07:30AM
Aug 7, 2025 07:30AM
May 15, 2025 07:00AM
Mar 31, 2025 01:11PM
Mar 31, 2025 07:00AM
Jan 13, 2025 08:00AM Cabaletta Bio Outlines Strategic Priorities and Anticipated Key Milestones for 2025
Nov 14, 2024 07:00AM
Aug 8, 2024 09:25AM
Aug 8, 2024 07:00AM
May 15, 2024 07:00AM
Mar 21, 2024 07:00AM
Nov 9, 2023 08:05AM
Nov 9, 2023 07:00AM Cabaletta Bio Reports Third Quarter 2023 Financial Results and Provides Business Update
Aug 16, 2023 08:08AM
Aug 10, 2023 07:00AM
May 11, 2023 07:00AM
Mar 16, 2023 07:00AM
Mar 16, 2023 07:00AM
Dec 8, 2022 07:02AM
Dec 8, 2022 07:00AM Cabaletta Bio Announces $35 Million Offering
Dec 8, 2022 07:00AM
Nov 10, 2022 07:00AM
Nov 10, 2022 07:00AM
Aug 11, 2022 07:09AM
Aug 11, 2022 07:00AM
Aug 11, 2022 07:00AM
May 12, 2022 07:00AM Cabaletta Bio Reports First Quarter 2022 Financial Results and Provides Business Update
May 12, 2022 07:00AM
Apr 22, 2022 09:00PM
Apr 17, 2022 09:00PM
Apr 11, 2022 09:00PM
Apr 1, 2022 09:00PM
Mar 27, 2022 09:00PM
Mar 21, 2022 09:00PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Affirm, Cabaletta, Ericsson, and C3.ai and Encourages Investors to Contact the Firm
Mar 17, 2022 07:02AM
Mar 17, 2022 07:00AM
Mar 17, 2022 07:00AM
Mar 16, 2022 09:00PM
Mar 11, 2022 09:00PM
Mar 6, 2022 09:00PM
Nov 1, 2021 07:05AM Cabaletta Bio Reports Third Quarter 2021 Financial Results and Provides Business Update
Nov 1, 2021 07:05AM
Aug 5, 2021 07:30AM
Aug 5, 2021 07:30AM
May 3, 2021 07:05AM
May 3, 2021 07:05AM
Mar 16, 2021 07:30AM
Mar 16, 2021 07:30AM Cabaletta Bio Reports Fourth Quarter and Full Year 2020 Financial Results and Provides a Business Update
Nov 10, 2020 07:30AM

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All